NDC 64725-1837

Novolin 70/30

Human Insulin

Novolin 70/30 is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by Tya Pharmaceuticals. The primary component is Insulin Human.

• Product ID: 64725-1837_05dc7def-3137-4c5c-8d43-2baf9d7888df
• NDC: 64725-1837
• Product Type: Human Otc Drug
• Proprietary Name: Novolin 70/30
• Generic Name: Human Insulin
• Dosage Form: Injection, Suspension
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 1991-06-25
• Marketing Category: NDA / NDA
• Application Number: NDA019991
• Labeler Name: TYA Pharmaceuticals
• Substance Name: INSULIN HUMAN
• Active Ingredient Strength: 100 [USP'U]/mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 64725-1837-1

10 mL in 1 VIAL, GLASS (64725-1837-1)

• Marketing Start Date: 1991-06-25
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 64725-1837-1 [64725183701]

Novolin 70/30 INJECTION, SUSPENSION

• Marketing Category: NDA
• Application Number: NDA019991
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 1991-06-25
• Inactivation Date: 2019-11-27

Drug Details

Active Ingredients

Ingredient	Strength
INSULIN HUMAN	100 [USP'U]/mL

OpenFDA Data

• SPL SET ID: 0cc57309-01ef-4a02-8d27-b981c768135a
• Manufacturer:
  • TYA Pharmaceuticals
• UNII:
  • 1Y17CTI5SR
• RxNorm Concept Unique ID - RxCUI:
  • 311048
  • 213442

NDC Crossover Matching brand name "Novolin 70/30" or generic name "Human Insulin"

NDC	Brand Name	Generic Name
0169-1833	Novolin	Human Insulin
0169-1834	Novolin	Human Insulin
0169-1837	Novolin	Human Insulin
0169-3003	Novolin	Human Insulin
0169-3004	Novolin	Human Insulin
0169-3007	Novolin	Human Insulin
50090-0403	Novolin	Human Insulin
50090-0497	Novolin	Human Insulin
50090-0498	Novolin	Human Insulin
64725-1833	Novolin	Human Insulin
64725-1834	Novolin	Human Insulin
64725-1837	Novolin	Human Insulin
68071-1701	Novolin	Human Insulin